Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
Abstract Background New emerging infections have no known treatment.Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control.However, it is difficult to launch clinical trials in the unpredictable environment of an outbreak.We conducted a bibliometric